News

Hepatitis C increases cancer risk

11-May-07

Hepatitis C increases the risk of non-Hodgkins lymphoma
Hepatitis C infection increases the risk of developing non-Hodgkin’s lymphoma by up to 30 per cent, claim US scientists.

For the study, 146,394 patients with hepatitis C and 572,293 people free from the infection were retrospectively assessed for cancer incidence. This revealed 1,359 cases of non-Hodgkin's lymphoma and 165 cases of Waldenström macroglobulinaemia.

People infected with hepatitis C were 20-30 per cent more likely to have non-Hodgkin's lymphoma than controls.

They were three times more likely to have Waldenström macroglobulinaemia.

Screening patients with hepatitis C infection for lymphoproliferative conditions could lead to early intervention, said the researchers.

rachel.liddle@haymarket.com

JAMA 2007; 297: 2,010-7

What do you think? Comment below or email us at healthcare.republic@haymarket.com  

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

RCGP Curriculum - 15.8 Respiratory Problems

This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more

RCGP Curriculum - 15.10 Skin Problems

This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more

RCGP Curriculum - 15.6 Metabolic Problems

This section of our curriculum guide refers to statement 15.6, Metabolic Problems, produced by the R... Read more

Show all articles

 

Latest Clinical Articles

Chronic constipation

Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more

Sexually transmitted infections

Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more

Pemphigus

Contributed by Dr Sacha Goolamali, dermatology specialist registrar and Dr Rachael Morris-Jones, con... Read more

Show all clinical articles

MIMS Product News

New drug - NuvaRing

A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more

New drug - Siklos

Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more

New drug - Bridion

Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more

Jobs

 

Job of the Week